Furthermore, interrogation of the KM-Plotter BC database (https://kmplot.com/analysis/) showed increased mRNA expression levels of Kindlin-2 correlate with poor disease outcome in patients with BC tumors, irrespective of subtype (Fig. S1C and [15]), and specifically in patients with TNBC tumors, at the mRNA levels (Fig. S1D), and at the protein levels (Fig. S1E). Here, FERMT2 is linked to breast cancer.